Dermatology

MHRA bans certain Dermapen devices

The Medicines and Healthcare products Regulatory Agency (MHRA) has released an alert for practitioners to stop using the Dermapen 3 device, the Dermapen 3 needle tips and the Dermapen Cryo device due to potential risk of injury or infection.

Read More »

Study highlights inaccuracy of eczema apps

A study published in the British Journal of Dermatology has suggested that 34% of eczema smartphone apps contain information that is inconsistent with international guidelines, particularly relating to treatments and progression of the condition.

Read More »

Candela Vascular Day, Amsterdam

Practitioners met at the Amsterdam Universitair Medische Centra Department of Dermatology in the Netherlands on May 18 to learn about the latest developments in laser technologies for vascular conditions from device manufacturer, Candela.

Read More »